I Insilico Medicine
Updates & Highlights
Bioengineer.org · about 18 hours ago
Insilico Medicine and SK Biopharmaceuticals Forge $2.5 Billion AI-Driven
Startup Fortune · about 22 hours ago
Insilico Medicine signs a $2.5 billion AI drug discovery deal with SK Biopharmaceuticals for neuroimmune disorders
Fortune · 1 day ago
AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion
Recent Openings
View all 3 jobs arrow_forwardMachine Learning Engineer (LLM Architect – Target ID) (UAE)
location_on Remote, GB
All Jobs
Machine Learning Engineer (LLM Architect – Target ID) (UAE)
location_on Remote, GB
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Insilico Medicine?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentInsilico Medicine and SK Biopharmaceuticals Forge $2.5 Billion AI-Driven
Insilico Medicine and SK Biopharmaceuticals Forge $2.5 Billion AI-Driven
Bioengineer.org · about 18 hours ago
Insilico Medicine signs a $2.5 billion AI drug discovery deal with SK Biopharmaceuticals for neuroimmune disorders
Insilico Medicine signs a $2.5 billion AI drug discovery deal with SK Biopharmaceuticals for neuroimmune disorders
Startup Fortune · about 22 hours ago
AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion
AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion
Fortune · 1 day ago
Insilico Medicine and SK Biopharmaceuticals Form AI-Powered Drug Discovery Collaboration for Neuroimmune CNS Disorders
Insilico Medicine and SK Biopharmaceuticals Form AI-Powered Drug Discovery Collaboration for Neuroimmune CNS Disorders
BioPharm International · 1 day ago
Korea's SK Biopharma collaborates with Insilico Medicine for $2.5 B AI-drug discovery deal
Korea's SK Biopharma collaborates with Insilico Medicine for $2.5 B AI-drug discovery deal
BioSpectrum Asia · 1 day ago
Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders
Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders
Insilico Medicine · 1 day ago
Insilico Medicine to showcase AI-driven drug breakthroughs at BIO 2026 International Convention
Insilico Medicine to showcase AI-driven drug breakthroughs at BIO 2026 International Convention
News-Medical · 5 days ago
Insilico Medicine synthesizes new Nav1.8 blockers
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld News · 5 days ago
Insilico Medicine’s ISM8969 Enters Phase 1 Trial, Advancing Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation and CNS Disorders
Insilico Medicine’s ISM8969 Enters Phase 1 Trial, Advancing Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation and CNS Disorders
geneonline.com · 6 days ago
Insilico Medicine Achieves First Clinical Milestone for AI-Designed NLRP3 Inhibitor ISM8969
Insilico Medicine Achieves First Clinical Milestone for AI-Designed NLRP3 Inhibitor ISM8969
BioPharma APAC · 6 days ago
Insilico Medicine Achieves First Clinical Milestone for AI-Designed NLRP3 Inhibitor ISM8969
Insilico Medicine Achieves First Clinical Milestone for AI-Designed NLRP3 Inhibitor ISM8969
BioPharma APAC · 6 days ago
Number of shareholders of INSILICO MEDICINE CAYMAN TOPCO – OTC:ISLMF
Number of shareholders of INSILICO MEDICINE CAYMAN TOPCO – OTC:ISLMF
TradingView · 19 days ago
Insilico Medicine founder and CEO Alex Zhavoronkov recognized in inaugural SCW75 for pioneering AI-driven drug discovery and longevity research
Insilico Medicine founder and CEO Alex Zhavoronkov recognized in inaugural SCW75 for pioneering AI-driven drug discovery and longevity research
EurekAlert! · 19 days ago
Insilico Medicine appoints Jue Wang, PhD as Global Head of Business Development
Insilico Medicine appoints Jue Wang, PhD as Global Head of Business Development
EurekAlert! · 20 days ago
Insilico Medicine Appoints Jue Wang, PhD as Global Head of Business Development
Insilico Medicine Appoints Jue Wang, PhD as Global Head of Business Development
Insilico Medicine · 21 days ago
Insilico Medicine to showcase AI-driven innovation at BIO 2026 International Convention
Insilico Medicine to showcase AI-driven innovation at BIO 2026 International Convention
EurekAlert! · 26 days ago
Human Longevity's Launched New Entity Human Life Foundation Models, Inc. and Insilico Medicine Collaborates to Build the First Foundation Model for Longevity Science
Human Longevity's Launched New Entity Human Life Foundation Models, Inc. and Insilico Medicine Collaborates to Build the First Foundation Model for Longevity Science
PR Newswire · 27 days ago
Insilico Medicine and Human Life Foundation Models Announce Collaboration to Co-Develop Industry-First Ai Foundation Model for Longevity Science
Insilico Medicine and Human Life Foundation Models Announce Collaboration to Co-Develop Industry-First Ai Foundation Model for Longevity Science
marketscreener.com · 28 days ago
Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science
Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science
The Manila Times · 28 days ago
Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science
Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science
Insilico Medicine · 29 days ago